Clinical Trials Browser

Recruiting × Sezary Syndrome × Brentuximab Vedotin × Clear all

NCT03587844 2025-11-03

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

Phase 2 Recruiting

Mycosis Fungoides, Sezary Syndrome, Lymphomatoid Papulosis